Wangxue Chen Selected Research

Wangxue Chen Research Topics

Disease

41	Infections 11/2022 - 03/2003
8	Tularemia 05/2008 - 05/2003
4	Pneumonia (Pneumonitis) 01/2021 - 08/2013
4	Inflammation (Inflammations) 01/2019 - 03/2003
3	Neoplasms (Cancer) 08/2021 - 10/2005
3	Respiratory Syncytial Virus Infections 01/2021 - 01/2019
3	Body Weight (Weight, Body) 01/2021 - 07/2008
3	Human Influenza (Influenza) 10/2020 - 01/2016
2	Communicable Diseases (Infectious Diseases) 08/2021 - 12/2010
2	Sepsis (Septicemia) 01/2019 - 09/2015
2	Bacteremia 05/2016 - 04/2015
2	Bacterial Infections (Bacterial Infection) 09/2009 - 07/2005
2	Hemorrhage 07/2005 - 03/2003
1	Osteoporosis 12/2022
1	Disease Progression 11/2021
1	COVID-19 11/2021
1	Virus Diseases (Viral Diseases) 11/2021
1	Bites and Stings (Sting) 08/2021
1	Vaccinia 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Carcinoma (Carcinomatosis) 10/2020
1	Tachypnea 01/2019
1	Airway Obstruction (Choking) 01/2019
1	Experimental Melanoma 01/2018
1	Neuroblastoma 01/2017
1	Cross Infection (Nosocomial Infection) 05/2016
1	Ventilator-Associated Pneumonia 05/2016
1	Reinfection 01/2016
1	Asthma (Bronchial Asthma) 01/2011
1	Healthcare-Associated Pneumonia 10/2009

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 11/2021 - 09/2003
8	CytokinesIBA 01/2020 - 10/2004
8	AerosolsIBA 01/2008 - 05/2003
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2004
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 12/2007
5	AntigensIBA 12/2019 - 08/2004
4	AntibodiesIBA 11/2021 - 10/2010
4	ChemokinesIBA 01/2020 - 05/2008
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 12/2004
3	Hemagglutinins (Hemagglutinin)IBA 10/2020 - 01/2016
3	Toll-Like Receptor 4IBA 09/2015 - 10/2004
3	Oxidoreductases (Dehydrogenase)IBA 05/2011 - 12/2004
3	Interferon-gamma (Interferon, gamma)IBA 03/2006 - 03/2003
2	Peptides (Polypeptides)IBA 11/2022 - 10/2020
2	3-hydroxypyridin-4-oneIBA 01/2021 - 01/2019
2	Neuraminidase (Sialidase)IBA 10/2020 - 01/2016
2	GlycolipidsIBA 11/2019 - 01/2018
2	LipidsIBA 11/2019 - 07/2008
2	Immunoglobulin G (IgG)IBA 11/2019 - 01/2016
2	Virulence Factors (Pathogenicity Factors)IBA 01/2019 - 03/2007
2	Respiratory Syncytial Virus VaccinesIBA 01/2019 - 01/2019
2	LipopolysaccharidesIBA 09/2015 - 03/2009
2	bis(3',5')-cyclic diguanylic acidIBA 09/2011 - 09/2009
2	NADP (NADPH)IBA 05/2011 - 03/2009
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 03/2009 - 12/2004
2	Messenger RNA (mRNA)IBA 05/2008 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007 - 06/2004
2	FibrinIBA 07/2005 - 03/2003
1	Indicators and Reagents (Reagents)IBA 12/2022
1	Heme (Haem)IBA 11/2021
1	InterferonsIBA 08/2021
1	GlycopeptidesIBA 10/2020
1	human ERBB2 proteinIBA 10/2020
1	Bacterial LysatesIBA 08/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	Subunit VaccinesIBA 01/2020
1	EmulsionsIBA 11/2019
1	SqualeneIBA 11/2019
1	Vaccine AdjuvantsIBA 11/2019
1	MucinsIBA 11/2019
1	Chelating AgentsIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	IronIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Phytic Acid (Inositol Hexaphosphate)IBA 01/2019
1	Chemokine CCL5IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	ChitosanIBA 01/2019
1	SirtuinsIBA 01/2017
1	Viral AntigensIBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Immunoglobulin A (IgA)IBA 01/2016
1	GinsenosidesIBA 09/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Imipenem FDA Link 08/2013
1	Tigecycline (Tygacil)FDA Link 08/2013
1	Immunologic Factors (Immunomodulators)IBA 09/2011
1	AllergensIBA 01/2011
1	GpGpIBA 09/2009
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2009
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2008
1	Monocyte Chemoattractant ProteinsIBA 12/2007
1	Monoclonal AntibodiesIBA 12/2007

Therapy/Procedure

1	Intranasal Administration 01/2021
1	Oral Administration 01/2019
1	Therapeutics 01/2019
1	Catheters 01/2019